Literature DB >> 18720522

Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.

Anuradha Poonepalli1, Birendranath Banerjee, Kalpana Ramnarayanan, Nallasivam Palanisamy, Thomas Choudary Putti, M Prakash Hande.   

Abstract

A study was undertaken to correlate telomere dysfunction and genomic instability with the histopathological grades and the estrogen and progesterone receptor status in breast cancer. Sixty-one archived breast tissues (38 cancer tissues and 23 paired normal tissues) were used in the study. The breast tumor tissues showed significantly shorter telomeres (7.7 kb) compared with the paired adjacent tissues (9.0 kb) by Southern blot analysis. Moreover, telomere shortening was more significant in Grade III tumors than in the Grade II tumors (P = 0.05). Quantitative fluorescence in situ hybridization on paraffin tissue sections revealed a similar trend in telomere shortening. Telomere attrition was associated with telomere dysfunction as revealed by the presence of significantly higher anaphase bridges in tumor cells which was tumor grade dependent. Furthermore, estrogen receptive negative tumors displayed higher anaphase and internuclear bridges. Selected samples from each grade showed greater genomic imbalances in the higher grades than the lower grade tumors as detected by array-comparative genomic hybridization. Telomerase activity was found to be higher in the higher grades (Grade II and III) compared with the lower grade (Grade I). The average mRNA expression of TRF1 and POT1 was lower in the tumor tissues than in the normal tissues. Tankyrase 1 mRNA expression showed a grade-dependent increase in tumor tissues and its expression was also high in estrogen and progesterone negative tumors. The data support the notion that telomere dysfunction might be of value as a marker of aggressiveness of the tumors in breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720522     DOI: 10.1002/gcc.20608

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  16 in total

1.  Elevated TRF2 in advanced breast cancers with short telomeres.

Authors:  Malissa C Diehl; Michael O Idowu; Katherine N Kimmelshue; Timothy P York; Colleen K Jackson-Cook; Kristi C Turner; Shawn E Holt; Lynne W Elmore
Journal:  Breast Cancer Res Treat       Date:  2010-07-13       Impact factor: 4.872

Review 2.  Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review.

Authors:  Kumari Anuja; Souvick Roy; Chinmoy Ghosh; Priya Gupta; Surajit Bhattacharjee; Birendranath Banerjee
Journal:  Inflamm Res       Date:  2016-09-21       Impact factor: 4.575

3.  RCP is a human breast cancer-promoting gene with Ras-activating function.

Authors:  Jinqiu Zhang; Xuejing Liu; Arpita Datta; Kunde Govindarajan; Wai Leong Tam; Jianyong Han; Joshy George; Christopher Wong; Kalpana Ramnarayanan; Tze Yoong Phua; Wan Yee Leong; Yang Sun Chan; Nallasivam Palanisamy; Edison Tak-Bun Liu; Krishna Murthy Karuturi; Bing Lim; Lance David Miller
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

4.  Chromosome 9 arm-specific telomere length and breast cancer risk.

Authors:  Yun-Ling Zheng; Christopher A Loffredo; Peter G Shields; Sahar M Selim
Journal:  Carcinogenesis       Date:  2009-06-17       Impact factor: 4.944

5.  Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Authors:  Stephen A Whelan; Ming Lu; Jianbo He; Weihong Yan; Romaine E Saxton; Kym F Faull; Julian P Whitelegge; Helena R Chang
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

Review 6.  Non-canonical roles of canonical telomere binding proteins in cancers.

Authors:  Semih Can Akincilar; Claire Hian Tzer Chan; Qin Feng Ng; Kerem Fidan; Vinay Tergaonkar
Journal:  Cell Mol Life Sci       Date:  2021-02-18       Impact factor: 9.261

7.  Clinico-Pathological Correlation of β-Catenin and Telomere Dysfunction in Head and Neck Squamous Cell Carcinoma Patients.

Authors:  Swatishree Padhi; Arka Saha; Madhabananda Kar; Chinmoy Ghosh; Amit Adhya; Manas Baisakh; Nachiketa Mohapatra; Shriram Venkatesan; Manoor Prakash Hande; Birendranath Banerjee
Journal:  J Cancer       Date:  2015-01-15       Impact factor: 4.207

8.  Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.

Authors:  Xi Wu; Hiromi Tanaka
Journal:  Oncotarget       Date:  2015-10-06

9.  Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.

Authors:  Kimberly S Butler; William C Hines; Christopher M Heaphy; Jeffrey K Griffith
Journal:  Cancer Med       Date:  2012-07-24       Impact factor: 4.452

10.  Shorter telomere length of T-cells in peripheral blood of patients with lung cancer.

Authors:  Yaqin Qian; Tingting Ding; Lijuan Wei; Shui Cao; Lili Yang
Journal:  Onco Targets Ther       Date:  2016-05-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.